CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Labcorp Holdings (LH) — Total Revenues by Quarter
Labcorp Holdings (LH) — Total Revenues ($M)
Cvs Health Labcorp Holdings (LH) — Total Revenues: $3,731M in Q2 2026, up 5.8% from a year earlier.
Latest, Q2 2026
3,731
Period ended Jun 30, 2026
Change on a year earlier
+5.8%
3,527 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
2
Documents cited below
Where the Q2 2026 figure comes from
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Cvs Health Labcorp Holdings (LH) — Total Revenues ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer-lh-revenue
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.